Target intelligence / Profile preview

AMZ2 pseudogene 1 (AMZ2P1)

Target
AMZ2P1
Molecular classification
Other (Pseudogene)
01

Overview

AMZ2 pseudogene 1 (AMZ2P1, also known as FLJ32065) is a processed pseudogene located in the human genome. Pseudogenes are DNA sequences similar to known genes but generally nonfunctional due to mutations or loss of regulatory elements, and they do not code for functional proteins. Although historically considered "junk DNA," certain pseudogenes have been shown to play roles in gene regulation, for example by serving as decoys for microRNAs or generating regulatory RNAs such as siRNAs that can impact mRNA stability or translation of parental genes. However, there is no evidence as of now that AMZ2P1 itself has a specific biological or disease-related function, nor is it considered a therapeutic target[1][3]. In summary, AMZ2P1 is classified as a pseudogene rather than a functional protein or receptor, and is not recognized as a drug target, with no known role as a biomarker or involvement in any therapeutic mechanism.

Other names
FLJ32065
02

Biological functions

Other (may regulate coding genes at the RNA level, such as acting as microRNA decoys or producing siRNA)
03

Disease associations

Other (individual pseudogenes have been implicated in cancer and metabolic diseases through gene regulation, but no evidence specific for AMZ2P1)

Beyond the preview

Go deeper on AMZ2 pseudogene 1 (AMZ2P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on AMZ2 pseudogene 1 (AMZ2P1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call